CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cabaletta Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.48+0.07 (+4.96%)
Close on Oct 19, 2026
- Market cap
- $223.72M
- P/E (TTM)
- –
- Dividend yield
- –
Cabaletta Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Market Cap | $250.93M | $166.30M |
| Enterprise Value | $25.83M | $88.19M |
| PB Ratio | 1.19 | 2.03 |
| P/TBV Ratio | 1.19 | 2.29 |
Income (trailing twelve months)
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Operating Income | -$185.52M | -$21.40M |
| Net Income | -$181.32M | -$22.46M |
| EBITDA | -$185.52M | -$16.91M |
Returns
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -93.2% | -53.2% |
| Return on Assets (ROA) | -75.4% | -40.9% |
| Return on Capital Employed (ROCE) | -85.6% | -38.1% |
Balance sheet
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $225.10M | $61.43M |
| Net Cash (Debt) | $225.10M | $15.35M |
| Net Cash Per Share | $1.33 | $0.66 |
| Equity (Book Value) | $210.59M | $49.09M |
| Book Value Per Share | $1.24 | $1.37 |
| Tangible Book Value | $210.59M | $23.52M |
| Working Capital | $191.12M | $76.81M |
Financial position
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Current Ratio | 5.79 | 3.34 |
| Quick Ratio | 5.64 | 2.44 |
| Interest Coverage | -80.94 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$153.93M | -$12.35M |
| Capital Expenditures | -$283.00K | -$1.08M |
| Free Cash Flow | -$154.21M | -$20.22M |
| FCF Per Share | -$0.91 | -$0.42 |
Efficiency
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$1.16M | -$703.34K |
| Employee Count | 156 | 74 |
Dividends and yields
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Earnings Yield | -72.3% | -23.3% |
| FCF Yield | -61.5% | -8.72% |
| Buyback Yield | -42.5% | -0.59% |
| Shareholder Yield | -42.5% | 0.00% |
Shares
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Shares Outstanding | 169,545,000 | 58,127,000 |
| Float | 166,210,000 | 49,136,700 |
| Shares Held by Insiders | 1.97% | 11.6% |
| Shares Held by Institutions | 93.6% | 59.4% |
Taxes
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | Cabaletta Bio | Industry median |
|---|---|---|
| Altman Z-Score | -1.56 | -0.22 |
Calculated by StockData from Cabaletta Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.